Dual-payload CD276 ADC(The Ohio State University)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameDual-payload CD276 ADC(The Ohio State University)
Drug Alias NameDual-payload ADC(The Ohio State University)Dual-payload CD276 antibody drug conjugate(The Ohio State University)CD276 Dual payload ADC(The Ohio State University)Hu276DualADC
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-CD276Toll like receptor 7 agonistsToll like receptor 8 agonists
TargetsCD276 antigenToll like receptor 7Toll like receptor 8
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesCamelot BioCapital LLCThe Ohio State University
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A